Castration resistant prostate cancer

You have access
Ra-223 and Ethinylestradiol Combination Therapy in Castration-resistant Prostate Cancer
TAKAFUMI SHIMADA, KOUJI IZUMI, HIROSHI KANO, SUGURU KADOMOTO, TOMOYUKI MAKINO, RENATO NAITO, HIROAKI IWAMOTO, HIROSHI YAEGASHI, YOSHIFUMI KADONO and ATSUSHI MIZOKAMI

Anticancer Research February 2022, 42 (2) 1065-1071; DOI: https://doi.org/10.21873/anticanres.15568
You have access
Therapeutic Effect of Ethinylestradiol in Castration-resistant Prostate Cancer
TAITO NAKANO, YOSHIFUMI KADONO, HIROAKI IWAMOTO, HIROSHI YAEGASHI, MASASHI IIJIMA, SHOHEI KAWAGUCHI, TAKAHIRO NOHARA, KAZUYOSHI SHIGEHARA, KOUJI IZUMI and ATSUSHI MIZOKAMI

Anticancer Research April 2020, 40 (4) 2291-2296; DOI: https://doi.org/10.21873/anticanres.14194
You have access
Combining Desmopressin and Docetaxel for the Treatment of Castration-Resistant Prostate Cancer in an Orthotopic Model
ROMAN BASS, DOMENICA ROBERTO, DANIEL ZONGJIE WANG, FERNANDO PENA CANTU, REZA M. MOHAMADI, SHANA O. KELLEY, LAURENCE KLOTZ and VASUNDARA VENKATESWARAN

Anticancer Research January 2019, 39 (1) 113-118; DOI: https://doi.org/10.21873/anticanres.13086

Main menu